Status and phase
Conditions
Treatments
About
This study is a prospective, multicenter, phase II randomized controlled trial. We plan to screen 100 eligible thymoma patients for robotic-assisted thoracoscopic thymectomy (RATT) or video-assisted thoracoscopic thymectomy (VATT) at three medical centers in China. The trial was aimed to compare the perioperative outcomes between the two approaches.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
The patients whose tumor diameter was not larger than 8 cm; The patients with the estimated survival time should be over 12 months; ASA grade:1-2; The patients should have no functional disorders in main organs; The patients should be able to understand our research and sign the informed consent.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
100 participants in 2 patient groups
Loading...
Central trial contact
Jianyong Ding, Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal